Transoral robotic surgery and human papillomavirus status: Oncologic results

Head and Neck

Volumn 33, Issue 4, 2011, Pages 573-580

  Cohen, Marc A ^a   Weinstein, Gregory S ^a   O'Malley Jr , Bert W ^a   Feldman, Michael ^a   Quon, Harry ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

human papillomavirus (HPV); minimally invasive surgery; oropharyngeal squamous cell carcinoma (OPSCC); transoral robotic surgery (TORS)

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; CAUSE SPECIFIC SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE CONTROL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; ORAL SURGERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; ROBOTICS; SEROTYPE; SURVIVAL; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PAPILLOMAVIRIDAE; PROGNOSIS; ROBOTICS; SURVIVAL RATE;

EID: 79952916886     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21500     Document Type: Article

References (47)

1. Parkin DM, Pisani P, Ferlay J,. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64. (Pubitemid 29094960)
2. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156. (Pubitemid 32911406)
3. Herrero R, Castellsagué X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-1783. (Pubitemid 38008900)
4. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D,. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999; 109: 1544-1551. (Pubitemid 29477216)
5. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720. (Pubitemid 30365531)
6. van Houten VM, Snijders PJ, van den Brekel MW, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001; 93: 232-235. (Pubitemid 32574279)
7. El-Mofty SK, Lu DW,. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003; 27: 1463-1470. (Pubitemid 37315200)
8. Franceschi S, Muñoz N, Snijders PJ,. How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet 2000; 356: 871-872.
9. Gillison ML, Koch WM, Shah KV,. Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease? Curr Opin Oncol 1999; 11: 191-199. (Pubitemid 29229613)
10. Gillison ML, Shah KV,. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 2001; 13: 183-188. (Pubitemid 32433975)
11. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131. (Pubitemid 32285233)
12. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001; 92: 2875-2884.
13. Schwartz SR, Yueh B, McDougall JK, Daling JR, Schwartz SM,. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001; 125: 1-9. (Pubitemid 33661083)
14. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747. (Pubitemid 46622040)
15. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820. (Pubitemid 47417302)
16. Gillison ML,. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744-754. (Pubitemid 39602680)
17. Clayman GL, Stewart MG, Weber RS, El-Naggar AK, Grimm EA,. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg 1994; 120: 743-748. (Pubitemid 24217588)
18. Snijders PJ, Scholes AG, Hart CA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996; 66: 464-469. (Pubitemid 26176767)
19. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM,. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-813. (Pubitemid 32783066)
20. Li W, Thompson CH, O'Brien CJ, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003; 106: 553-558. (Pubitemid 36966212)
21. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636. (Pubitemid 46631302)
22. Cohen MA, Basha SR, Reichenbach DK, Robertson E, Sewell DA,. Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta Otolaryngol 2008; 128: 583-589. (Pubitemid 351550952)
23. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269. (Pubitemid 351480538)
24. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008; 26: 3138-3146.
25. Hockstein NG, Nolan JP, O'Malley BW Jr, Woo YJ,. Robotic microlaryngeal surgery: a technical feasibility study using the daVinci surgical robot and an airway mannequin. Laryngoscope 2005; 115: 780-785. (Pubitemid 40604679)
26. Hockstein NG, Nolan JP, O'Malley BW Jr, Woo YJ,. Robot-assisted pharyngeal and laryngeal microsurgery: results of robotic cadaver dissections. Laryngoscope 2005; 115: 1003-1008. (Pubitemid 40776991)
27. Hockstein NG, O'Malley BW Jr, Weinstein GS,. Assessment of intraoperative safety in transoral robotic surgery. Laryngoscope 2006; 116: 165-168. (Pubitemid 44383917)
28. O'Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG,. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006; 116: 1465-1472. (Pubitemid 44181466)
29. Weinstein GS, O'Malley BW Jr, Snyder W, Sherman E, Quon H,. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007; 133: 1220-1226. (Pubitemid 350294250)
30. Obiso R, Lorincz A,. Digene Corporation. Pharmacogenomics 2004; 5: 129-132. (Pubitemid 38088484)
31. Holsinger FC, McWhorter AJ, Ménard M, Garcia D, Laccourreye O,. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results. Arch Otolaryngol Head Neck Surg 2005; 131: 583-591. (Pubitemid 41058047)
32. Moore EJ, Henstrom DK, Olsen KD, Kasperbauer JL, McGree ME,. Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope 2009; 119: 508-515.
33. Weinstein GS, O'Malley BW Jr, Cohen MA, Quon H,. Transoral robotic surgery (TORS) for advanced oropharyngeal squamous cell carcinoma: a prospective single arm cohort study. Am Acad of Otolaryngol Head and Neck Society 2009.
34. Kies MS, Holsinger FC, Lee JJ, et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol 2010; 28: 8-14.
35. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 2009; 119: 1542-1549.
36. Gillison ML, Harris J, Westra W, et al. Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129. J Clin Oncol (Meeting Abstracts) 2009; 27: 6003.
37. Straetmans JM, Olthof N, Mooren JJ, de Jong J, Speel EJ, Kremer B,. Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009; 119: 1951-1957.
38. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J, et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer. Radiother Oncol 2010; 94: 30-35.
39. Rischin D, Young R, Fisher R, et al. Prognostic significance of HPV and p16 status in patients with oropharyngeal cancer treated on a large international phase III trial. J Clin Oncol (Meeting Abstracts) 2009; 27: 6004.
40. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila Pa) 2009; 2: 776-781.
41. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
42. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. (Pubitemid 38580197)
43. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3-11. (Pubitemid 23137882)
44. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 51: 571-578.
45. Dosoretz A, Dutta P, Alons-Basanta M, et al. Long-term percutaneous gastrostomy tube dependence rates in patients treated with intensity-modulated radiotherapy for oropharyngeal cancer: the University of Pennsylvania Experience. ASTRO Multidisciplinary Head and Neck Cancer Symposium. Chandler, Arizona, 2009.
46. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439. (Pubitemid 39601860)
47. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.